TMSB4X and acute myeloid leukemia: This study had for aim to compare cell proliferation of 29 AML patients by two methods i) S phase evaluation and DNA content for proliferation assessment and ii) PKH67 labelling to monitor proliferation of living blast treated or not cytostatic drugs or AcSDKP a regulator of stem cells.